Abstract
Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder. © 2005 Wiley-Liss, Inc.
Author supplied keywords
Cite
CITATION STYLE
APA
Gertz, M. A. (2005, June). Waldenström macroglobulinemia: A review of therapy. American Journal of Hematology. https://doi.org/10.1002/ajh.20363
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free